Examining the Cognitive Neuroscience of Psychedelics
The new REBUS model helps explain the subjective and neurochemical effects of psychedelics on the brain.
The new REBUS model helps explain the subjective and neurochemical effects of psychedelics on the brain.
The catalog of compounds for use in psychedelic drug research continues to grow.
The researchers hope these compounds “will expand the universe of options for improving mental health.”
With the paradigm shift created by psychedelics, a recent study suggests reconsidering the medical model of mental illness.
Scientific research does not support his statements that psychedelics are “very potent” and “very dangerous.”
Comments from Matthew Johnson of Johns Hopkins provide an update on this research.
Three clinical trials are underway to find out if these psychedelic compounds can provide relief for patients.
Understanding the pharmacology of magic mushrooms is not just about tryptamines anymore.
Surprisingly, 4-HO-TMT has binding affinity similar to psilocin at 5-HT2A.
These creatures have more in common with humans than one might suspect.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.